Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values

International Journal of COPD

Volumn 9, Issue , 2014, Pages 675-683

  Dal Negro, Roberto W ^a   Bonadiman, Luca ^a   Tognella, Silvia ^b   Bricolo, Fernanda P ^c   Turco, Paola ^c  

^a National Centre of Studies of Pharmacoeconomics and Respiratory Pharmacoepidemiology (CESFAR)   (Italy)

^b Lung Division Bussolengo General Hospital   (Italy)

^c Research and Clinical Governance   (Italy)

Author keywords

Chronic airway flow limitation; Chronic bronchitis; Cognition; Copd; Smoke

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CHRONIC BRONCHITIS; CHRONIC NON OBSTRUCTIVE BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOCK DRAWING TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; PREVALENCE; PSYCHOMETRY; SMOKING; TRAIL MAKING TEST A; TRAIL MAKING TEST B; VERY ELDERLY; BRONCHITIS; CASE CONTROL STUDY; COGNITION DISORDERS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; LUNG; PATHOPHYSIOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHITIS; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TRAIL MAKING TEST;

EID: 84903582584     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S63485     Document Type: Article

References (40)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
2. Sullivan SD, Ramsey SD, Lee TA, et al. The economic burden of COPD. Chest. 2000;117(Suppl 2):5S-9S.
3. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188-207.
4. Aït-Khaled N, Enarson DA, Ottmani S, El Sony A, Eltigani M, Sepulveda R, et al. Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis. 2007;2(2):141-150.
5. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121(9): 789-796.
6. Calverley PM. Neuropsycological deficits in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1996;51(1):5-6.
7. Ambrosino N, Bruletti G, Scala V, Porta R, Vitacca M, et al. Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study. Intensive Care Med. 2002;28(2):170-177.
8. Antonelli-Incalzi C, Corsonello A, Troiano L, et al. Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord. 2007;23(4):264-270.
9. Dodd JW, Getov SV, Jones PW, et al. Cognitive function in COPD. Eur Respir J. 2010;35(4):913-922.
10. Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J. 1962;86:257-260.
11. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol. 1986;2(4):261-276.
12. Ward T, Dawe B, Procter A, Murphy E, Weinman J, et al. Assessment in severe dementia: the Guy's Advanced Dementia Schedule. Age Ageing. 1993;22(3):183-189.
13. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6(1):63-68.
14. Semenza C, Mondini S, Borgo F, Pasini M, Sgaramella MT, et al. Proper names in patients with early Alzheimer's disease. Neurocase. 2003;9(1):63-69.
15. Ritchie K, Touchon J, et al. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355(9199):225-228.
16. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM, et al. Neurophysiological findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470-1476.
17. Krzyzanowski M, Jedrychowski W, Wysocki M, et al. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134(5):1011-1019.
18. Kuller LH, Ockene JK, Townsend M, Browner W, Meilahn E, Wentworth DN, et al. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis. 1989;140(3 Pt 2):S76-S81.
19. Chyou PH, White LR, Yano K, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol. 1996;143(8):750-756.
20. Incalzil RA, Bellia V., et al. Salute Respiratoria nell'Anziano Study Group. Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction. Aging Clin Exp Res. 2002;14(5): 395-401.
21. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivelä SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996;8(1):113-125.
22. Pleis JR, Leithbridge-Cejku M, et al. Summary Health Statistics for US adults: National Health Interview Survey, 2006. Hyattsville, MD: Vital and Health Statistics, US Department of Health and Human Services; 2007;20-23.
23. Anstey KJ, Windsor TD, Jorm AF, Christensen H, Rodgers B, et al. Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004;50(4):230-234.
24. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308.
25. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-1142.
26. Hung WW, Wisnivesky JP, Siu AL, Ross JS, et al. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(2):134-137.
27. Kozora E, Emery CF, Zhang L, Make B, et al. Improved neurobehavioral functioning in emphysema patients following medical therapy. J Cardiopulm Rehabil Prev. 2010;30(4):251-259.
28. Albert MS, Jones K, Savage CR, et al. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging. 1995;10(4):578-589.
29. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58(5):758-764.
30. Maruta C, Guerreiro M, de Mendonça A, Hort J, Scheltens P, et al. The use of neuropsycological tests across Europe: the need for a consensus in the use of assessment tools for dementia. Eur J Neurol. 2011;18(2): 279-285.
31. Kozora E, Filley CM, Julian LJ, Cullum CM, et al. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(3):178-183.
32. Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease - a neuropsychological and spect study. J Neurol. 2003;250(3):325-332.
33. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.
34. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
35. Folstein MF, Folstein SE, McHugh PR, et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
36. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996;17(4):305-309.
37. Brown EC, Casey A, Fisch RI, Neuringer C. Trail making test as a screening device for the detection of brain damage. J Consult Psychol. 1958;22(6):469-474.
38. Huppert FA. Memory impairment associated with chronic hypoxia. Thorax. 1982;37(11):858-860.
39. Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis. 1993;148(2):418-424.
40. Liensker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med. 2004;98(4):351-356.